A. OĞUL Et Al. , "The Importance of Parameters: MPV, MPV/Thrombocyte Ratio and Neutrophil/Lymphocyte Ratio in Sorafenib Treatment Response of Patients with Hepatocellular Cancer," JOURNAL OF GASTROINTESTINAL CANCER , vol.48, no.3, pp.286-287, 2017
OĞUL, A. Et Al. 2017. The Importance of Parameters: MPV, MPV/Thrombocyte Ratio and Neutrophil/Lymphocyte Ratio in Sorafenib Treatment Response of Patients with Hepatocellular Cancer. JOURNAL OF GASTROINTESTINAL CANCER , vol.48, no.3 , 286-287.
OĞUL, A., ŞAHİN, B., KUŞCU, F., Taktakoglu, O., YETİŞİR, A. E., BÜYÜKŞİMŞEK, M., ... MİRİLİ, C.(2017). The Importance of Parameters: MPV, MPV/Thrombocyte Ratio and Neutrophil/Lymphocyte Ratio in Sorafenib Treatment Response of Patients with Hepatocellular Cancer. JOURNAL OF GASTROINTESTINAL CANCER , vol.48, no.3, 286-287.
OĞUL, ALİ Et Al. "The Importance of Parameters: MPV, MPV/Thrombocyte Ratio and Neutrophil/Lymphocyte Ratio in Sorafenib Treatment Response of Patients with Hepatocellular Cancer," JOURNAL OF GASTROINTESTINAL CANCER , vol.48, no.3, 286-287, 2017
OĞUL, ALİ Et Al. "The Importance of Parameters: MPV, MPV/Thrombocyte Ratio and Neutrophil/Lymphocyte Ratio in Sorafenib Treatment Response of Patients with Hepatocellular Cancer." JOURNAL OF GASTROINTESTINAL CANCER , vol.48, no.3, pp.286-287, 2017
OĞUL, A. Et Al. (2017) . "The Importance of Parameters: MPV, MPV/Thrombocyte Ratio and Neutrophil/Lymphocyte Ratio in Sorafenib Treatment Response of Patients with Hepatocellular Cancer." JOURNAL OF GASTROINTESTINAL CANCER , vol.48, no.3, pp.286-287.
@article{article, author={ALİ OĞUL Et Al. }, title={The Importance of Parameters: MPV, MPV/Thrombocyte Ratio and Neutrophil/Lymphocyte Ratio in Sorafenib Treatment Response of Patients with Hepatocellular Cancer}, journal={JOURNAL OF GASTROINTESTINAL CANCER}, year=2017, pages={286-287} }